2008~2017年体外受精/卵胞浆内单精子显微注射周期取消新鲜胚胎移植的原因构成与变化

doi:10.6040/j.issn.1671-7554.0.2018.512

摘要/Abstract

摘要： 目的分析2008~2017年10年间行体外受精(IVF)/卵胞浆内单精子显微注射(ICSI)周期取消新鲜胚胎移植的原因构成及变化。方法回顾性分析2008年至2017年取消新鲜胚胎移植的17 601个IVF/ICSI周期,其中2008年至2012年3 018个周期、2013年至2017年14 583个周期,根据取消原因分为预防卵巢过度刺激综合征(OHSS)、注射人绒毛膜促性腺激素(HCG)日孕酮值升高、子宫内膜因素、胚胎因素、输卵管积水及其他因素,分析10年间取消鲜胚移植的原因构成比,并进一步按女性不同年龄组(≥35岁和<35岁)及不同用药方案进行分层分析。结果 IVF/ICSI取消新鲜胚胎移植的主要原因是OHSS风险,近10年在各年龄组发生率均有上升趋势。≥35岁患者取消移植的主要原因是胚胎因素,<35岁患者取消移植的主要原因是OHSS风险。因输卵管积水取消鲜胚移植的比例近10年在各年龄组中均有增加。长方案、拮抗剂方案及超长方案取消鲜胚移植的主要原因是预防OHSS,短方案、微刺激方案主要原因是胚胎因素。结论目前IVF/ICSI取消鲜胚移植的主要原因是OHSS风险,其次为胚胎因素、内膜因素。年龄越大,胚胎原因取消移植所占比例越高。有效预防卵巢高反应、提高高龄女性胚胎质量、积极控制盆腔炎症是降低鲜胚移植取消率、改善辅助生殖技术妊娠结局的有效措施。

关键词: 鲜胚移植, 全胚冷冻, 卵巢过度刺激综合征, 子宫内膜, 孕酮

Abstract: Objective To analyze the proportion and changes of causes resulting in the cancellation of fresh embryo transfer of in vitro fertilization(IVF)/intracytoplasmic sperm injection(ICSI)from 2008 to 2017 in the Reproductive Hospital Affiliated to Shandong University. Methods A retrospective analysis was performed among 17 601 cycles of IVF/ICSI fresh embryo transfer cancellation, including 3 018 cycles during 2008 and 2012, and 14 583 cycles during 2013 and 2017. The causes of cancellation included ovarian hyperstimulation syndrome(OHSS), high level of serum progesterone, endometrial factors, poor embryo quality, hydrosalpinx, and others. Further analysis was performed 山东大学学报 (医学版)56卷9期 -范华蕊,等. 2008~2017年体外受精/卵胞浆内单精子显微注射周期取消新鲜胚胎移植的原因构成与变化 \=-according to the female age(<35 years and ≥35 yrs)and different protocols. Results The major cause for cancellation was OHSS risk, which showed an increasing trend in all age groups in the past 10 years. For women ≥35 years, the dominant cause was poor embryo quality, whereas for women <35 years, the major cause was OHSS risk. An obvious increase was observed in the proportion of hydrosalpinx in all age groups in the past 10 years. For long, GnRH antagonist and ultra-long GnRHa protocols, the prominent cause for cancellation was OHSS risk. For short, mini-stimulation protocols, the major cause was poor embryo quality. Conclusion OHSS risk was the commonest cause for cancellation of fresh embryo transfer, followed by poor embryo quality and endometrial factors. Embryo quality was a challenge for female of advanced aged. Effective methods could be considered to reduce the rate of cancellation, such as preventing ovarian hyperresponsiveness, improving embryo quality, and controlling pelvic inflammation.

Key words: Fresh embryo transfer, Embryos freezing, Ovarian hyperstimulation syndrome, Endometrium, Progesterone

中图分类号:

R711.6

范华蕊,张洋,郭情情,李福侠,唐蓉,盛燕,丁玲玲,秦莹莹. 2008~2017年体外受精/卵胞浆内单精子显微注射周期取消新鲜胚胎移植的原因构成与变化[J]. 山东大学学报 (医学版), 2018, 56(9): 47-53.

FAN Huarui, ZHANG Yang, GUO Qingqing, LI Fuxia, TANG Rong, SHENG Yan, DING Lingling, QIN Yingying. Analysis on the proportion and changes of causes for cancellation of fresh embryo transfer from 2008 to 2017[J]. Journal of Shandong University (Health Sciences), 2018, 56(9): 47-53.

参考文献

[1] 徐蓓, 靳镭. 在高反应人群中如何预防卵巢过度刺激综合征[J]. 生殖医学杂志, 2017, 26(11): 1071-1074. XU Bei, JIN Lei. How to prevent OHSS in patients with high ovarian response?[J]. Journal of Reproductive Medicine, 2017, 26(11): 1071-1074.
[2] Lawrenz B, Labarta E, Fatemi H, et al. Premature progesterone elevation: targets and rescue strategies[J]. Fertil Steril, 2018, 109(4): 577-582.
[3] 陈子江, 刘新民, 李媛, 等. 人类生殖与辅助生殖[M]. 北京: 科学出版社, 2005: 701-702.
[4] 刘平, 乔杰. 生殖医学实验室技术[M]. 北京: 北京大学医学出版社, 2013: 106-109.
[5] Griesinger G, Verweij PJ, Gates D, et al. Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol[J]. PLoS One, 2016, 11(3): e0149615. doi: 10.1371/journal.pone.0149615.
[6] Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2017, 1: CD012103. doi: 10.1002/14651858.CD012103.pub2.
[7] Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type[J]. Hum Reprod Update, 2017, 23(5): 560-579.
[8] Wang R, Lin S, Wang Y, et al. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis[J]. PLoS One, 2017, 12(4): e0175985. doi: 10.1371/journal.pone.0175985.
[9] Dosouto C, Haahr T, Humaidan P. Gonadotropin-releasing hormone agonist(GnRHa)trigger-State of the art[J]. Reprod Biol, 2017, 17(1): 1-8.
[10] Dahan MH, Tannus S, Seyhan A, et al. Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation[J]. Gynecol Endocrinol, 2018, 34(3): 252-255.
[11] Fatemi HM, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone trigger[J]. Fertil Steril, 2015, 103(4): 870-873.
[12] Ashmita J, Vikas S, Swati G. The impact of progesterone level on day of HCG injection in IVF cycles on clinical pregnancy rate[J]. J Hum Reprod Sci, 2017, 10(4): 265-270.
[13] Venetis CA, Kolibianakis EM, Bosdou JK, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles[J]. Hum Reprod, 2015, 30(3): 684-691.
[14] Bu Z, Zhao F, Wang K, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study[J]. PLoS One, 2014, 9(6): e100011. doi: 10.1371/journal.pone.0100011.
[15] 刁俊荣, 张云山, 杜爱军, 等. HCG日孕酮升高对妊娠结局的影响及其早期预测因素的探讨[J]. 实用妇产科杂志, 2016, 32(1): 33-37. DIAO Junrong, ZHANG Yunshan, DU Aijun, et al. The impact of elevated progesterone on the day of HCG administration on pregnancy outcomes and its early prognostic factors[J]. Journal of Practical Obstetrics and Gynecology, 2016, 32(1): 33-37.
[16] Wang A, Santistevan A, Hunter Cohn K, et al. Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates[J]. Fertil Steril, 2017, 108(2): 254-261.
[17] Healy MW, Patounakis G, Connell MT, et al. Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?[J]. Fertil Steril, 2016, 105(1): 93-99.e1.
[18] 李元, 龚斐. GnRH-a促排周期中晚卵泡期孕酮上升的原因与策略[J]. 生殖医学杂志, 2017, 26(11): 1095-1099. LI Yuan, GONG Fei. The causes and countermeasures of premature elevation during the late follicular phase in GnRH-agonist cycles[J]. Journal of Reproductive Medicine, 2017, 26(11): 1095-1099.
[19] Gingold JA, Lee JA, Rodriguez-Purata J, et al. Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfers[J]. Fertil Steril, 2015, 104(3): 620-628.e5.
[20] Ribeiro VC, Santos-Ribeiro S, De Munck N, et al. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight[J]. Reprod Biomed Online, 2018, 36(4): 416-426.
[21] Amir W, Micha B, Ariel H, et al. Predicting factors for endometrial thickness during treatment with assisted reproductive technology[J]. Fertil Steril, 2007, 87(4): 799-804.
[22] Erel CT, Aydin Y, Kaleli S, et al. Is endometrial apoptosis evidence of endometrial aging in unexplained infertility? a preliminary report[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 121(2): 195-201.
[23] 刘芳, 高婷婷, 巨瑛, 等. 输卵管积水性不孕行新鲜胚胎移植的妊娠结局分析[J]. 中国妇幼健康研究, 2016, 27(7): 853-855. LIU Fang, GAO Tingting, JU Ying, et al. Pregnancy outcomes of fresh embryo transplantation in hydrosalpinx induced infertility patients[J]. Chinese Journal of Woman and Child Health Research, 2016, 27(7): 853-855.
[24] Sharma JB, Sneha J, Singh UB, et al. Comparative study of laparoscopic abdominopelvic and fallopian tube findings before and after antitubercular therapy in female genital tuberculosis with infertility[J]. J Minim Invasive Gynecol, 2016, 23(2): 215-222.
[25] Tsiami A, Chaimani A, Mavridis D, et al. Surgical treatment for hydrosalpinx prior to in-vitro fertilization embryo transfer: a network meta-analysis[J]. Ultrasound Obstet Gynecol, 2016, 48(4): 434-445.
[26] 吴佘玲, 唐蓉, 范秀玲, 等. 输卵管积水不同处理方式对体外受精-胚胎移植结局的影响: 一项回顾性队列研究[J]. 中华生殖与避孕杂志, 2018, 38(1): 11-15. WU Sheling, TANG Rong, FAN Xiuling, et al. Effects of different operation managements on in vitro fertilization and embryo transfer outcome: a retrospective cohort study[J]. Chinese Journal of Reproduction and Contraception, 2018, 38(1): 11-15.

相关文章 15

[1]	黄玉真,吕琛,颜磊,李帅帅,张景雪,刘超,王银霞,桑岩岩,房鹛. 基于危险因素筛查的延续性院外管理对卵巢过度刺激综合征的预防效果[J]. 山东大学学报 (医学版), 2026, 64(4): 92-99.
[2]	张舒淇,江延姣,印丹. 生殖道微生物与子宫内膜异位症发展之间的联系[J]. 山东大学学报 (医学版), 2025, 63(5): 120-126.
[3]	徐萍,张信美. 子宫内膜异位症疼痛的机制[J]. 山东大学学报 (医学版), 2025, 63(10): 1-7.
[4]	黄艳,周应芳,彭超. 青少年子宫内膜异位症的管理要点和策略[J]. 山东大学学报 (医学版), 2025, 63(10): 8-12.
[5]	薛铭,梁静,凌斌. 各种类型子宫内膜异位症疼痛特点及治疗研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 13-19.
[6]	赵书睿,赵烨. 围绝经期及绝经后期子宫内膜异位症的诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(10): 20-26.
[7]	梁炎春,严莹,麦华希,姚书忠. 地诺孕素在子宫内膜异位症相关性疼痛中的治疗作用:从基础到临床[J]. 山东大学学报 (医学版), 2025, 63(10): 27-33.
[8]	董向毅,刘昕,刘欣欣,徐亚瑄,赵琳丽,陶国伟. 盆腔深部子宫内膜异位症的超声评价[J]. 山东大学学报 (医学版), 2025, 63(10): 34-42.
[9]	刘振花,连雅囡,米国琳. 子宫内膜异位症疼痛的心理因素及干预措施的研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 43-51.
[10]	杜煜晗,孙莹,杜惠兰. 红花如意丸对寒凝血瘀型子宫内膜异位症痛经患者疼痛的疗效及机制[J]. 山东大学学报 (医学版), 2025, 63(10): 52-60.
[11]	张扬,刘帅,邓明铭,王秋敏,黄玉真,颜磊. 宫腔镜子宫内膜息肉切除至取卵的时间间隔对IVF/ICSI鲜胚移植妊娠结局的影响[J]. 山东大学学报 (医学版), 2025, 63(10): 80-88.
[12]	赵圣蕊,曲慧灵,许鑫鑫,张芳芳,颜磊. 体外受精/卵胞浆内单精子注射-胚胎移植后稽留流产采用药物流产和清宫术效果比较[J]. 山东大学学报 (医学版), 2024, 62(2): 69-74.
[13]	李军秀,袁莹莹,黄凌燕,赵君利. 子宫内膜CD38表达对胚胎移植前抗炎治疗的临床价值[J]. 山东大学学报 (医学版), 2023, 61(8): 54-60.
[14]	吴磊丽,蔡华丽,孙德胜,魏蔚霞. 超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效[J]. 山东大学学报 (医学版), 2023, 61(6): 65-69.
[15]	许月明,张杰,姜蕾,尹力,赵畔,许欣,郝桂敏. 扳机日孕酮升高与获卵数对辅助生殖技术新鲜周期妊娠结局的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 44-50.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed